Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The Positive Predictive Value of BI-RADS Microcalcification Descriptors and Final Assessment Categories
211
Zitationen
4
Autoren
2010
Jahr
Abstract
OBJECTIVE: The purpose of this article is to retrospectively assess the likelihood of malignancy of microcalcifications according to the BI-RADS descriptors in a digital mammography environment. MATERIALS AND METHODS: The study included 146 women with calcifications who underwent imaging-guided biopsy between April 2005 and July 2006. Digital mammograms procured before biopsy were analyzed independently by two breast imaging subspecialists blinded to biopsy results. Lesions described discordantly were settled by consensus. One of the radiologists provided a BI-RADS final assessment score. RESULTS: The overall positive predictive value of biopsies was 28.8%. The individual morphologic descriptors predicted the risk of malignancy as follows: fine linear/branching, 16 (70%) of 23 cases; fine pleomorphic, 14 (28%) of 50 cases; coarse heterogeneous, two (20%) of 10 cases; amorphous, 10 (20%) of 51 cases; and typically benign, zero (0%) of 12 cases. Fisher-Freeman-Halton exact testing showed statistical significance among morphology descriptors (p < 0.001) and distribution descriptors (p < 0.001). The positive predictive value for malignancy according to BI-RADS assessment categories were as follows: category 2, 0%; category 3, 0%; category 4A, 13%; category 4B, 36%; category 4C, 79%; and category 5, 100%. CONCLUSION: BI-RADS morphology and distribution descriptors can aid in assessing the risk of malignancy of microcalcifications detected on full-field digital mammography. The positive predictive value increased in successive BI-RADS categories (4A, 4B, and 4C), verifying that subdivision provides an improved assessment of suspicious microcalcifications in terms of likelihood of malignancy.
Ähnliche Arbeiten
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 · 13.213 Zit.
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
2005 · 7.602 Zit.
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
2002 · 6.512 Zit.
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 · 6.333 Zit.
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 · 6.185 Zit.